IGF2BP2 and colorectal cancer: In colorectal cancer, knockdown of IGF2BP2 attenuates MYC-mediated glycolysis in colorectal cancer cells, and the LINRIS–IGF2BP2–MYC axis is a promising therapeutic target for colorectal cancer (42).